Schousboe, John T <br/><br/>
Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty.  [electronic resource] 

 -  The Journal of bone and joint surgery. American volume  Jul 2013 
 - 1256-64 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1535-1386 
<br/><br/><label>Standard No.: </label>10.2106/JBJS.L.00400  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Anticoagulants--economics<br/>Arthroplasty, Replacement--adverse effects<br/>Aspirin--economics<br/>Cost-Benefit Analysis<br/>Female<br/>Fibrinolytic Agents--economics<br/>Heparin, Low-Molecular-Weight--economics<br/>Humans<br/>Male<br/>Middle Aged<br/>Quality-Adjusted Life Years<br/>Venous Thromboembolism--drug therapy